MedPath

PHOENIX - Pre-eclampsia in HOspital: Early iNductIon or eXpectant management

Not Applicable
Completed
Conditions
Pre-eclampsia in women between 34+0 and 36+6 weeks of gestation
Pregnancy and Childbirth
Gestational [pregnancy-induced] hypertension with significant proteinuria
Registration Number
ISRCTN01879376
Lead Sponsor
King's College London
Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30691508 protocol (added 31/01/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31472930 results (added 02/09/2019) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34024312/ Results of PEACOCK nested study of prognostic model (added 25/05/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35861912/ Cost-utility analysis (added 22/07/2022) 2022 Funder report results in https://www.journalslibrary.nihr.ac.uk/hta/published-articles/CWWH0622/#/full-report (added 13/12/2022) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38757271/ Secondary analysis of PHOEBE (PHOENIX-3) sub-study data (added 21/05/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
901
Inclusion Criteria

Current inclusion criteria as of 05/10/2016:
1. Women between 34+0 and 36+6 weeks of gestation
2. Confirmed as having pre-eclampsia (as defined as defined by International Society for the Study of Hypertension in Pregnancy {ISSHP} 2014 statement)
3. Singleton or dichorionic diamniotic (DCDA) twin pregnancy
4. Aged 18 years or over at the time of screening
5. Able to give written informed consent

Previous inclusion criteria:
1. Women between 34+0 and 36+6 weeks of gestation
2. Confirmed as having pre-eclampsia (as defined by the NICE guidelines on Hypertension in Pregnancy)
3. An in-patient in a consultant-led maternity unit
4. Singleton or dichorionic diamniotic (DCDA) twin pregnancy
5. Aged 18 years or over at the time of screening
6. Able to give written informed consent

Exclusion Criteria

Women will be excluded from participating in the study if a decision has already been made to delivery within the next 48 hours

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath